San Miguel, Peru Clinical Trials

A listing of San Miguel, Peru clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 102 clinical trials
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

The purpose of this study is to determine whether treatment with alpelisib in combination with nab-paclitaxel is safe and effective in subjects with advanced triple negative breast cancer (aTNBC) who carry either a PIK3CA mutation (Study Part A) or have PTEN loss (Study Part B1) or PTEN loss without PIK3CA …

PTEN
metastasis
PIK3CA
paclitaxel
measurable disease
Novartis Investigative Site
 (8.5 away) Contact site
  • 5 views
  • 19 Sep, 2021
  • +153 other locations
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Primary Objective: To evaluate the anti-leukemic activity of isatuximab in combination with standard chemotherapies in pediatric participants of ages 28 days to less than 18 years with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Acute Myeloid Leukemia (AML) Secondary Objectives: Safety and tolerability assessments Assessment of infusion reactions (IRs) Pharmacokinetics (PK) …

asparaginase
idarubicin
mitoxantrone
lymphoid leukemia
hydroxyurea
Investigational Site Number 6040002
 (4.0 away) Contact site
  • 14 views
  • 14 Jun, 2021
  • +70 other locations
To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection

Summit is developing ridinilazole as a novel antimicrobial for Clostridium difficile Infection (CDI), formerly known as Clostridium difficile Infection, with the goal of achieving comparable cure rates to standard of care, but reducing rates of recurrent disease. A phase 2 proof of concept study, with vancomycin as comparator, demonstrated these …

vancomycin
clostridium difficile
diarrhea
antibiotics
antibiotic therapy
Hospital Nacional Alberto Sabogal Sologuren
 (2.0 away) Contact site
  • 18 views
  • 18 Apr, 2021
  • +181 other locations
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemotherapy administered prior to surgery compared with placebo and chemotherapy administered prior to surgery in terms of pathological complete response.

lung carcinoma
durvalumab
cancer chemotherapy
carboplatin
pemetrexed
Research Site
 (1.7 away) Contact site
  • 251 views
  • 02 Sep, 2021
  • +320 other locations
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199) With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination with venetoclax with and without obinutuzumab compared to chemoimmunotherapy in subjects with previously untreated CLL.

abt-199
obinutuzumab
acalabrutinib
chemoimmunotherapy
fludarabine
Research Site
 (8.5 away) Contact site
  • 342 views
  • 19 Sep, 2021
  • +245 other locations
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with BCG, compared to BCG monotherapy, in participants with HR NMIBC that is either persistent or recurrent following adequate BCG induction (Cohort A), or that is nave to BCG treatment (Cohort B). The primary hypothesis …

Hospital Militar Central [Lima, Peru] ( Site 0604)
 (2.6 away) Contact site
  • 108 views
  • 19 Sep, 2021
  • +141 other locations
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

Phase III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple-negative Breast Cancer (TNBC)

formalin-fixed paraffin-embedded
paclitaxel
measurable disease
breast cancer
cancer
Research Site
 (2.9 away) Contact site
  • 1387 views
  • 26 Aug, 2021
  • +309 other locations
Evaluation of Efficacy and Safety of Pamrevlumab in Patients With Idiopathic Pulmonary Fibrosis

This is a Phase 3 trial to evaluate the efficacy and safety of 30 mg/kg intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in subjects with Idiopathic Pulmonary Fibrosis

pamrevlumab
pirfenidone
nintedanib
idiopathic pulmonary fibrosis
diffusion capacity of the lung for carbon monoxide
Clinica Providencia
 (0.7 away) Contact site
  • 349 views
  • 19 Sep, 2021
  • +227 other locations
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

The purpose of this study is to evaluate the efficacy and safety of pembrolizumab plus concurrent chemoradiotherapy compared to placebo plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer. The primary hypotheses are that pembrolizumab plus concurrent chemoradiotherapy is superior to placebo plus concurrent chemoradiotherapy with respect to progression-free …

chemoradiotherapy
adenosquamous carcinoma
carcinoma
external beam radiation therapy
adenocarcinoma
Clinica San Gabriel ( Site 0296)
 (0.5 away) Contact site
  • 87 views
  • 19 Sep, 2021
  • +165 other locations
Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)

This is a 2-part, phase 3 clinical study evaluating the antiretroviral activity and safety/tolerability of islatravir (ISL), doravirine (DOR), and a fixed dose combination (FDC) of DOR/ISL (also known as MK-8591A) in heavily treatment-experienced (HTE) participants with human immunodeficiency virus type 1 (HIV-1) infection. It is hypothesized that the percentage …

Policlinico Universidad Nacional Mayor de San Marcos ( Site 4501)
 (2.4 away) Contact site
  • 118 views
  • 19 Sep, 2021
  • +102 other locations